{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T18:04:27Z","timestamp":1771437867027,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Heilongjiang Provincial Health Commission scientific research project, china","award":["YQJH2023051"],"award-info":[{"award-number":["YQJH2023051"]}]},{"name":"The project of Basic Research Support Plan for Outstanding Young Teachers in Heilongjiang Provincial universities, china","award":["20231111000188"],"award-info":[{"award-number":["20231111000188"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04465-8","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:05:52Z","timestamp":1769169952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic nomograms for predicting overall and cancer-specific survival in acute erythroid leukemia: a SEER-based study"],"prefix":"10.1007","volume":"17","author":[{"given":"Xin","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuemei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"4465_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094000","author":"Q Chen","year":"2025","unstructured":"Chen Q, Liu S, Wei X, Zhao P, Tian F, Yang K, et al. Dibromo-edaravone induces anti-erythroleukemia effects via the JAK2-STAT3 signaling pathway. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26094000.","journal-title":"Int J Mol Sci"},{"key":"4465_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105491","volume":"166","author":"W Long","year":"2021","unstructured":"Long W, Liu S, Li XX, Shen X, Zeng J, Luo JS, et al. Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells. Pharmacol Res. 2021;166:105491.","journal-title":"Pharmacol Res"},{"issue":"4","key":"4465_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Brit J Haematol. 1976;33(4):451\u20138.","journal-title":"Brit J Haematol"},{"issue":"20","key":"4465_CR4","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood"},{"issue":"11","key":"4465_CR5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328.","journal-title":"Blood"},{"key":"4465_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108612","volume":"163","author":"M Zhou","year":"2025","unstructured":"Zhou M, Yuan CM, He ZX, Long MT, He LT, Yang Y, et al. A natural flavagline derivative A2073 inhibits the proliferation of erythroleukemia cells by targeting the MAPK, PI3K, NF-kappaB, and cell cycle pathways. Bioorg Chem. 2025;163: 108612.","journal-title":"Bioorg Chem"},{"issue":"2","key":"4465_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","volume":"32","author":"P Boddu","year":"2018","unstructured":"Boddu P, Benton CB, Wang W, Borthakur G, Khoury JD, Pemmaraju N. Erythroleukemia-historical perspectives and recent advances in diagnosis and management. Blood Rev. 2018;32(2):96\u2013105.","journal-title":"Blood Rev"},{"issue":"9","key":"4465_CR8","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.5858\/2009-0350-RA.1","volume":"134","author":"Z Zuo","year":"2010","unstructured":"Zuo Z, Polski JM, Kasyan A, Medeiros LJ. Acute erythroid leukemia. Arch Pathol Lab Med. 2010;134(9):1261\u201370.","journal-title":"Arch Pathol Lab Med"},{"key":"4465_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116256","author":"P Fernandes","year":"2024","unstructured":"Fernandes P, Waldron N, Chatzilygeroudi T, Naji NS, Karantanos T. Acute erythroid leukemia: from molecular biology to clinical outcomes. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25116256.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4465_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-00765-5","volume":"21","author":"F Thol","year":"2020","unstructured":"Thol F, Ganser A. Treatment of relapsed acute myeloid leukemia. Curr Treat Options Oncol. 2020;21(8):66.","journal-title":"Curr Treat Options Oncol"},{"issue":"18","key":"4465_CR11","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1182\/blood.2023019804","volume":"143","author":"P Saultier","year":"2024","unstructured":"Saultier P, Michel G. How i treat long-term survivors of childhood acute leukemia. Blood. 2024;143(18):1795\u2013806.","journal-title":"Blood"},{"issue":"12","key":"4465_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s11864-022-01032-5","volume":"23","author":"SY Wu","year":"2022","unstructured":"Wu SY, Short NJ, Nasr L, Dabaja BS, Fang PQ. Central nervous system prophylaxis and treatment in acute leukemias. Curr Treat Options Oncol. 2022;23(12):1829\u201344.","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"4465_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11899-022-00680-6","volume":"17","author":"G Granroth","year":"2022","unstructured":"Granroth G, Khera N, Arana YC. Progress and challenges in survivorship after acute myeloid leukemia in adults. Curr Hematol Malig Rep. 2022;17(6):243\u201353.","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"4465_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"4465_CR15","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380.","journal-title":"Lancet Oncol"},{"key":"4465_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jad.2023.11.086","volume":"347","author":"L Liu","year":"2024","unstructured":"Liu L, Xiao Y, Wei D, Wang Q, Zhang JK, Yuan L, et al. Development and validation of a nomogram for predicting suicide risk and prognostic factors in bladder cancer patients following diagnosis: a population-based retrospective study. J Affect Disord. 2024;347:124\u201333.","journal-title":"J Affect Disord"},{"key":"4465_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101480","volume":"24","author":"Z Dong","year":"2022","unstructured":"Dong Z, Zhang Y, Geng H, Ni B, Xia X, Zhu C, et al. Development and validation of two nomograms for predicting overall survival and cancer-specific survival in gastric cancer patients with liver metastases: a retrospective cohort study from SEER database. Transl Oncol. 2022;24:101480.","journal-title":"Transl Oncol"},{"issue":"21","key":"4465_CR18","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res"},{"key":"4465_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116149","author":"C Andrieu-Soler","year":"2022","unstructured":"Andrieu-Soler C, Soler E. Erythroid cell research: 3D chromatin, transcription factors and beyond. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23116149.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4465_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41408-022-00746-x","volume":"12","author":"KK Reichard","year":"2022","unstructured":"Reichard KK, Tefferi A, Abdelmagid M, Orazi A, Alexandres C, Haack J, et al. Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases. Blood Cancer J. 2022;12(11):147.","journal-title":"Blood Cancer J"},{"key":"4465_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153941","author":"K Gera","year":"2023","unstructured":"Gera K, Martir D, Xue W, Wingard JR. Survival after pure (acute) erythroid leukemia in the United States: a SEER-based study. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15153941.","journal-title":"Cancers"},{"issue":"12","key":"4465_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278578","volume":"17","author":"Q Hao","year":"2022","unstructured":"Hao Q, Foroutan F, Han MA, Devji T, Nampo FK, Mukherjee S, et al. Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review. PLoS One. 2022;17(12): e278578.","journal-title":"PLoS One"},{"issue":"15","key":"4465_CR23","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1002\/cncr.28129","volume":"119","author":"MS Thein","year":"2013","unstructured":"Thein MS, Ershler WB, Jemal A, Yates JW, Baer MR. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer. 2013;119(15):2720\u20137.","journal-title":"Cancer"},{"issue":"12","key":"4465_CR24","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3324\/haematol.2012.066100","volume":"97","author":"B Oran","year":"2012","unstructured":"Oran B, Weisdorf DJ. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica. 2012;97(12):1916\u201324.","journal-title":"Haematologica"},{"issue":"5","key":"4465_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/modpathol.2017.175","volume":"31","author":"EF Reinig","year":"2018","unstructured":"Reinig EF, Greipp PT, Chiu A, Howard MT, Reichard KK. De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity. Mod Pathol. 2018;31(5):705\u201317.","journal-title":"Mod Pathol"},{"key":"4465_CR26","doi-asserted-by":"crossref","unstructured":"Almeida AM, Prebet T, Itzykson R, Ramos F, Al-Ali H, Shammo J, et al. Clinical outcomes of 217 patients with acute erythroleukemia according to treatment type and line: a retrospective multinational study. Int J Mol Sci. 2017;18(4)","DOI":"10.3390\/ijms18040837"},{"key":"4465_CR27","doi-asserted-by":"crossref","unstructured":"Gabbard T, Marini BL, Mirza KM, Benitez L, Fraga M, Pettit KM, et al. Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agents. J Oncol Pharm Pract. 2025:1072610118","DOI":"10.1177\/10781552251323578"},{"issue":"9","key":"4465_CR28","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.3324\/haematol.2021.280487","volume":"107","author":"H Fang","year":"2022","unstructured":"Fang H, Wang SA, Khoury JD, El HS, Kim DH, Tashakori M, et al. Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases. Haematologica. 2022;107(9):2232\u20137.","journal-title":"Haematologica."},{"issue":"1","key":"4465_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36139-8","volume":"13","author":"S Zhu","year":"2023","unstructured":"Zhu S, Lei C. Association between marital status and all-cause mortality of patients with metastatic breast cancer: a population-based study. Sci Rep. 2023;13(1):9067.","journal-title":"Sci Rep"},{"issue":"2","key":"4465_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ijgo.14750","volume":"162","author":"C Gao","year":"2023","unstructured":"Gao C, Li H, Wu R, Chen W. Prognostic nomogram and treatment efficacy analysis for vaginal cancer: a SEER database and external validation study. Int J Gynaecol Obstet. 2023;162(2):541\u201351.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"4465_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08904-3","volume":"21","author":"J Ding","year":"2021","unstructured":"Ding J, Wen Z. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database. BMC Cancer. 2021;21(1):1157.","journal-title":"BMC Cancer"},{"issue":"1","key":"4465_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-95783-4","volume":"15","author":"X Ouyang","year":"2025","unstructured":"Ouyang X, Wu X, Hu S, Jiang W, Guo Y, Huang Y. The demographic characteristics and prognosis of acute myeloid leukemia with t(3;3)\/inv(3) in the united states: a SEER-based study. Sci Rep. 2025;15(1):13477.","journal-title":"Sci Rep"},{"issue":"12","key":"4465_CR33","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/ijc.35125","volume":"155","author":"X Dou","year":"2024","unstructured":"Dou X, Dan C, Zhang D, Zhou H, He R, Zhou G, et al. Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: a multicenter study from China. Int J Cancer. 2024;155(12):2253\u201364.","journal-title":"Int J Cancer"},{"issue":"8","key":"4465_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-015-0355-3","volume":"16","author":"SB Zeichner","year":"2015","unstructured":"Zeichner SB, Arellano ML. Secondary adult acute myeloid leukemia: a review of our evolving understanding of a complex disease process. Curr Treat Options Oncol. 2015;16(8):37.","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"4465_CR35","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1002\/cncr.35214","volume":"130","author":"E Sedeta","year":"2024","unstructured":"Sedeta E, Jemal A, Nisotel L, Sung H. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt. Cancer. 2024;130(11):1952\u201363.","journal-title":"Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04465-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:05:10Z","timestamp":1771434310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04465-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4465"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04465-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used the SEER public database, which contains de-identified, publicly available data. Therefore, ethics approval was not required.\u00a0Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and\u00a0consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}